BSX vs GSBC · P/E 20, rev $16.75B vs P/E 12, $798.6M cap
Boston Scientific Corp (BSX) versus Great Southern Bancorp Inc (GSBC) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Great Southern Bancorp Inc (GSBC) is a banks - regional company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
GSBC does not have a complete income-statement cache yet.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. GSBC currently screens at market cap $798.6M and trailing P/E 11.6.
Not investment advice. Open the BSX and GSBC stock pages for the full models.
Not investment advice.